PW Medtech Group Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
178.00
249.00
255.00
183.00
888.00
576.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
1.00
51.00
-17.00
15.00
14.00
65.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
308.00
399.00
281.00
353.00
113.00
82.00
Cash Flow from Investing Activities
-22.00
-76.00
76.00
-1,297.00
3,108.00
2,319.00
Cash Flow from Financing Activities
-155.00
-228.00
-135.00
-100.00
-2,519.00
-637.00
Net Cash Inflow / Outflow
131.00
100.00
229.00
-1,049.00
702.00
1,763.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
5.00
6.00
-5.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of PW Medtech Group Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
178.939849029009
414.824683
-236.00
-56.86%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
1.8935778052817
-98.01764
99.00
101.93%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
308.530631120026
308.440015
0.00
0.03%
Cash Flow from Investing Activities
-22.2739409879013
-175.586451
153.00
87.31%
Cash Flow from Financing Activities
-155.134561041647
70.39146
-225.00
-320.39%
Net Cash Inflow / Outflow
131.072241015424
225.563572
-94.00
-41.89%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.0498880750532408
22.318548
-22.00
-100.22%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is -22.82% vs 42.04% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
308.53
399.75
-22.82%






